Skip to content

Acute Coronary Syndrome in Diabetic Patients

Comparing Clinical Profile and Outcomes of Acute Coronary Syndrome in Diabetic and Non-Diabetic Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03607201
Enrollment
86
Registered
2018-07-31
Start date
2017-08-01
Completion date
2018-08-31
Last updated
2018-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Acute Pulmonary Edema, Cardiac Arrythmias, Diabetes Mellitus, Heart Failure

Keywords

acute coronary syndrome, diabetes, heart failure, acute pulmonary edema, malignant arrhythmia

Brief summary

This study aims to compare the clinical profile and outcomes of acute coronary syndrome patients with diabetes and without diabetes.

Detailed description

Adult patients (≥ 18 years of age) with acute coronary syndrome which are diagnosed under International Classification of Disease (ICD-10) coding of I24.9 were included in this study. The inclusion criteria are patients with primary diagnosis of I24.9 and with a complete record of prior medical and treatment history, electrocardiographic findings, cardiac marker results and outcomes. Participants were grouped into 2 groups - diabetic and non-diabetic based on history of diabetes prior to ACS. Diagnosis of ACS was made based on clinical, electrocardiographic and cardiac marker findings found in the medical record. Data such as age, sex, ethnic, education, prior medical and treatment history, electrocardiographic and cardiac enzyme results as well as outcomes were collected from the patients' medical records. Outcomes of interest were defined as either concomitant heart failure, acute lung edema, malignant arrhythmia, mortality or combinations of them as diagnosed in the medical records. Heart failure is defined based on echocardiographic findings from the medical records. Acute Lung Edema is defined based on medical records or reported clinical findings of lung edema - rhonchi reported in 1/3 of the lungs with oxygen saturation \<90%. Whereas malignant arrhythmia is defined as the presence of ventricular tachycardia (VT) or ventricular fibrillation (VF).

Interventions

OTHERNo intervention

Routine care

Sponsors

Cengkareng General Hospital
CollaboratorOTHER
Tarumanagara University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Acute Coronary Syndrome * Presence of detail on diabetes history

Exclusion criteria

* Unavailability of electrocardiographic findings, cardiac marker results * Incomplete records of prior medical and treatment history

Design outcomes

Primary

MeasureTime frameDescription
MortalityThrough study completion, an average of 1 yearPatient death reported in medical records
Cardiogenic ShockThrough study completion, an average of 1 yearClinical Diagnosis of Cardiogenic Shock reported in medical records
Recurrent Myocardial InfarctionThrough study completion, an average of 1 yearClinical Diagnosis of Recurrent Myocardial Infarction reported in medical records
Heart FailureThrough study completion, an average of 1 yearBased on echocardiographic findings from the medical records
Malignant ArrhythmiaThrough study completion, an average of 1 yearPresence of ventricular tachycardia (VT) or ventricular fibrillation (VF)
Acute Lung EdemaThrough study completion, an average of 1 yearBased on medical records or reported clinical findings of lung edema - rhonchi reported in 1/3 of the lungs with oxygen saturation \<90%.

Other

MeasureTime frameDescription
TIMI ScoreThrough study completion, an average of 1 yearThrombolysis In Myocardial Infarction (TIMI) mortality risk score
GRACE ScoreThrough study completion, an average of 1 yearGRACE (Global Registry of Acute Coronary Events) mortality risk score

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026